CLAIM #12098 · Bristol-Myers Squibb Company (BMY) · 2024Q4 earnings call · Feb 6, 2025 · due Dec 31, 2027
“As we said, an incremental. It's a $2 billion program, all that dropping to the bottom line. We said $1 billion of that which dropped this year with operating expenses of $16 billion the further $1 billion achieved by 2027 would get you to operating expenses of $15.”
David Elkins · CFO
PENDING
graded after results covering Dec 31, 2027 are reported
How to check this claim
Look at: Total operating expenses, annual
It came true if: Operating expenses <= $15 billion for fiscal year 2027 (vs. $16 billion baseline referenced)
Where: Company income statement / annual report (10-K), fiscal year 2027
Verify independently
SEC filings for BMY ↗ · Claim quote is verbatim from the 2024Q4 earnings call.